Tag: TRI FDA FVT TDS

IDEAYA Biosciences Announces Proffered Paper Oral Presentation at ESMO 2025 for Phase 2 Clinical Trial of Neoadjuvant Darovasertib in Primary Uveal Melanoma

The presentation will include data from over 90 patients in both the plaque brachytherapy and enucleation-eligible cohortsDarovasertib has received U.S. FDA Breakthrough Therapy Designation...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsTRI FDA FVT TDS

As XRP Crosses $200 Billion Market Cap, HashJ Expands Support for Scalable XRP & Dogecoin Contract Rewards

Mohawk Industries 发布 2025 年第二季度财报

Mohawk Industries 公布 2025 年第二季度業績

Tag: TRI FDA FVT TDS

IDEAYA Biosciences Announces Proffered Paper Oral Presentation at ESMO 2025 for Phase 2 Clinical Trial of Neoadjuvant Darovasertib in Primary Uveal Melanoma

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us